TrialThe Journal of clinical endocrinology and metabolism2025

Safety, Growth, and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up).

Naim Shehadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.